# miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/mir-130a-can-predict-response-to-temozolomide-in-patients-with-glioblastoma/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Huiyuan Chen,Xinyi Li,Wenbin Li,Huyong Zheng |
| Citations | 45 |
| DOI | 10.1186/s12967-015-0435-y |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://translational-medicine.biomedcentral.com/counter/pdf/10.1186/s12967-015-0435-y |
| OpenAlex ID | https://openalex.org/W2152158152 |
| PMID | 25890369 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Huyong Zheng](https://scholariq.org/researchers/huyong-zheng/)

## Paper journal

- [Journal of Translational Medicine](https://scholariq.org/journals/journal-of-translational-medicine/)

## Paper primary topic

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)

## Paper topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [MicroRNA in disease regulation](https://scholariq.org/topics/microrna-in-disease-regulation/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.